Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 282

1.

Patient and provider perspectives on adherence to and care coordination of lynch syndrome surveillance recommendations: findings from qualitative interviews.

Schneider JL, Goddard KAB, Muessig KR, Davis JV, Rope AF, Hunter JE, Peterson SK, Acheson LS, Syngal S, Wiesner GL, Reiss JA.

Hered Cancer Clin Pract. 2018 May 10;16:11. doi: 10.1186/s13053-018-0090-4. eCollection 2018.

2.

Challenges in recruiting African-American women for a breast cancer genetics study.

Compadre AJ, Simonson ME, Gray K, Runnells G, Kadlubar S, Zorn KK.

Hered Cancer Clin Pract. 2018 Apr 24;16:8. doi: 10.1186/s13053-018-0091-3. eCollection 2018.

3.

Retraction Note to: The BRCA2 variant c.68-7 T > A is associated with breast cancer.

Møller P, Hovig E.

Hered Cancer Clin Pract. 2018 May 2;16:10. doi: 10.1186/s13053-018-0093-1. eCollection 2018.

4.

Platinum-based neoadjuvant chemotherapy in BRCA1-positive breast cancer: a retrospective cohort analysis and literature review.

Sæther NH, Skuja E, Irmejs A, Maksimenko J, Miklasevics E, Purkalne G, Gardovskis J.

Hered Cancer Clin Pract. 2018 Apr 27;16:9. doi: 10.1186/s13053-018-0092-2. eCollection 2018.

5.

CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome.

Cremin C, Howard S, Le L, Karsan A, Schaeffer DF, Renouf D, Schrader KA.

Hered Cancer Clin Pract. 2018 Mar 7;16:7. doi: 10.1186/s13053-018-0088-y. eCollection 2018.

6.

Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland.

Kluz T, Jasiewicz A, Marczyk E, Jach R, Jakubowska A, Lubiński J, Narod SA, Gronwald J.

Hered Cancer Clin Pract. 2018 Feb 27;16:6. doi: 10.1186/s13053-018-0089-x. eCollection 2018.

7.

Genetic variants of prospectively demonstrated phenocopies in BRCA1/2 kindreds.

Dominguez-Valentin M, Evans DGR, Nakken S, Tubeuf H, Vodak D, Ekstrøm PO, Nissen AM, Morak M, Holinski-Feder E, Martins A, Møller P, Hovig E.

Hered Cancer Clin Pract. 2018 Jan 15;16:4. doi: 10.1186/s13053-018-0086-0. eCollection 2018.

8.

BRCA1 and BRCA2 mutation spectrum - an update on mutation distribution in a large cancer genetics clinic in Norway.

Heramb C, Wangensteen T, Grindedal EM, Ariansen SL, Lothe S, Heimdal KR, Mæhle L.

Hered Cancer Clin Pract. 2018 Jan 10;16:3. doi: 10.1186/s13053-017-0085-6. eCollection 2018.

9.

Central nervous system gadolinium accumulation in patients undergoing periodical contrast MRI screening for hereditary tumor syndromes.

Vergauwen E, Vanbinst AM, Brussaard C, Janssens P, De Clerck D, Van Lint M, Houtman AC, Michel O, Keymolen K, Lefevere B, Bohler S, Michielsen D, Jansen AC, Van Velthoven V, Gläsker S.

Hered Cancer Clin Pract. 2018 Jan 5;16:2. doi: 10.1186/s13053-017-0084-7. eCollection 2018.

10.

Evaluation of a 27-gene inherited cancer panel across 630 consecutive patients referred for testing in a clinical diagnostic laboratory.

Gardner SA, Weymouth KS, Kelly WS, Bogdanova E, Chen W, Lupu D, Suhl J, Zeng Q, Geigenmüller U, Boles D, Okamoto PM, McDowell G, Hayden MA, Nagan N.

Hered Cancer Clin Pract. 2018 Jan 4;16:1. doi: 10.1186/s13053-017-0083-8. eCollection 2018.

11.

Exome sequencing characterizes the somatic mutation spectrum of early serrated lesions in a patient with serrated polyposis syndrome (SPS).

Horpaopan S, Kirfel J, Peters S, Kloth M, Hüneburg R, Altmüller J, Drichel D, Odenthal M, Kristiansen G, Strassburg C, Nattermann J, Hoffmann P, Nürnberg P, Büttner R, Thiele H, Kahl P, Spier I, Aretz S.

Hered Cancer Clin Pract. 2017 Nov 29;15:22. doi: 10.1186/s13053-017-0082-9. eCollection 2017.

12.

The BRCA2 variant c.68-7 T>A is associated with breast cancer.

Møller P, Hovig E.

Hered Cancer Clin Pract. 2017 Nov 13;15:20. doi: 10.1186/s13053-017-0080-y. eCollection 2017. Retraction in: Hered Cancer Clin Pract. 2018 May 2;16:10.

13.

Clinical and genetic characterization of hereditary breast cancer in a Chinese population.

Jian W, Shao K, Qin Q, Wang X, Song S, Wang X.

Hered Cancer Clin Pract. 2017 Oct 30;15:19. doi: 10.1186/s13053-017-0079-4. eCollection 2017.

14.

Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report.

Seppälä T, Pylvänäinen K, Evans DG, Järvinen H, Renkonen-Sinisalo L, Bernstein I, Holinski-Feder E, Sala P, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Jenkins M, Genuardi M, Green K, Lalloo F, Sunde L, Mints M, Bertario L, Pineda M, Navarro M, Morak M, Frayling IM, Plazzer JP, Sampson JR, Capella G, Möslein G, Mecklin JP, Møller P; Mallorca Group.

Hered Cancer Clin Pract. 2017 Oct 10;15:18. doi: 10.1186/s13053-017-0078-5. eCollection 2017.

15.

Emotional impact on the results of BRCA1 and BRCA2 genetic test: an observational retrospective study.

Mella S, Muzzatti B, Dolcetti R, Annunziata MA.

Hered Cancer Clin Pract. 2017 Oct 2;15:16. doi: 10.1186/s13053-017-0077-6. eCollection 2017.

16.

The potential role of miRNAs in therapy of breast and ovarian cancers associated with BRCA1 mutation.

Strumidło A, Skiba S, Scott RJ, Lubiński J.

Hered Cancer Clin Pract. 2017 Sep 29;15:15. doi: 10.1186/s13053-017-0076-7. eCollection 2017. Review.

17.

Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review.

Meiser B, Wong WKT, Peate M, Julian-Reynier C, Kirk J, Mitchell G.

Hered Cancer Clin Pract. 2017 Sep 20;15:14. doi: 10.1186/s13053-017-0075-8. eCollection 2017. Review.

18.

Evaluation of psychosocial aspects in participants of cancer genetic counseling.

González-Ramírez LP, Martínez-Arriaga R, Camacho-Cárdenas E, Del Toro-Valero A, Oceguera-Villanueva A, Zagamé L, Silva-García AA, Daneri-Navarro A.

Hered Cancer Clin Pract. 2017 Sep 20;15:13. doi: 10.1186/s13053-017-0073-x. eCollection 2017.

19.

Hereditary gynaecologic cancers in Nepal: a proposed model of care to serve high risk populations in developing countries.

Pokharel HP, Hacker NF, Andrews L.

Hered Cancer Clin Pract. 2017 Sep 18;15:12. doi: 10.1186/s13053-017-0072-y. eCollection 2017.

20.

Preoperative genetic testing impacts surgical decision making in BRCA mutation carriers with breast cancer: a retrospective cohort analysis.

Yadav S, Reeves A, Campian S, Sufka A, Zakalik D.

Hered Cancer Clin Pract. 2017 Jul 26;15:11. doi: 10.1186/s13053-017-0071-z. eCollection 2017.

Supplemental Content

Loading ...
Support Center